A Study of NGM282 in Patients With Primary Sclerosing Cholangitis

NGM Clinical Study Site 118, Sacramento

NGM Clinical Study Site 112, San Clemente

NGM Clinical Study Site 127, San Francisco

NGM Clinical Study Site 106, Aurora

NGM Clinical Study Site 115, Washington D.C.

NGM Clinical Study Site 110, Gainesville

NGM Clinical Study Site 124, Lakewood Rch

NGM Clinical Study Site 105, Miami

NGM Clinical Study Site 109, Indianapolis

NGM Clinical Study Site 104, Detroit

NGM Clinical Study Site 102, Kansas City

NGM Clinical Study Site 107, St Louis

NGM Clinical Study Site 103, New York

NGM Clinical Study Site 116, Durham

NGM Clinical Study Site 120, Cincinnati

NGM Clinical Study Site 114, Nashville

NGM Clinical Study Site 113, Dallas

NGM Clinical Study Site 117, Dallas

NGM Clinical Study Site 119, Houston

NGM Clinical Study Site 125, Southlake

NGM Clinical Study Site 111, Charlottesville

NGM Clinical Study Site 122, Newport News

NGM Clinical Study Site 101, Norfolk

NGM Clinical Study Site 121, Richmond

NGM Clinical Study Site 108, Seattle

NGM Clinical Study Site 126, Seattle

NGM Clinical Study Site 301, Paris

NGM Clinical Study Site 402, Amsterdam

NGM Clinical Study Site 407, Amsterdam

NGM Clinical Study Site 406, Leiden

NGM Clinical Study Site 401, Nijmegen

NGM Clinical Study Site 404, Rotterdam

NGM Clinical Study Site 405, Utrecht

NGM Clinical Study Site 505, Birmingham

NGM Clinical Study Site 504, Liverpool

NGM Clinical Study Site 502, London

NGM Clinical Study Site 501, Newcastle

NGM Clinical Study Site 503, Norwich